Second-quarter adjusted segment EBITDA increased 165% over the prior-year period to $13 million, and adjusted segment EBITDA margin expanded 790 basis points to 16.3%.
Excluding the impact of favorable foreign exchange translation and divestitures, adjusted segment EBITDA increased 45.6% compared to the prior-year period.
Adjusted EBITDA of $57.2 million increased 52.5% over the prior-year period as a result of higher operating leverage from solid organic sales growth, the addition of Alluxa, and increased pricing, partially offset by increased raw material costs and higher incentive compensation accruals.
Second-quarter sales of $59.2 million increased 48%, driven by continued strong growth in semiconductor and the addition of Alluxa.
